China Health Industries Holdings, Inc. (CHHE) Current Deferred Revenue (2016 - 2024)
China Health Industries Holdings (CHHE) has disclosed Current Deferred Revenue for 12 consecutive years, with $344272.0 as the latest value for Q1 2024.
- For the quarter ending Q1 2024, Current Deferred Revenue rose 102.64% year-over-year to $344272.0, compared with a TTM value of $344272.0 through Mar 2024, up 102.64%, and an annual FY2023 reading of $208966.0, down 55.76% over the prior year.
- Current Deferred Revenue was $344272.0 for Q1 2024 at China Health Industries Holdings, up from $248469.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $1.5 million in Q3 2022 and bottomed at $137543.0 in Q2 2020.
- Average Current Deferred Revenue over 5 years is $342370.4, with a median of $178272.0 recorded in 2020.
- The sharpest move saw Current Deferred Revenue soared 783.78% in 2022, then crashed 88.68% in 2023.
- Year by year, Current Deferred Revenue stood at $148926.0 in 2020, then grew by 23.59% to $184061.0 in 2021, then dropped by 5.34% to $174236.0 in 2022, then skyrocketed by 42.6% to $248469.0 in 2023, then skyrocketed by 38.56% to $344272.0 in 2024.
- Business Quant data shows Current Deferred Revenue for CHHE at $344272.0 in Q1 2024, $248469.0 in Q4 2023, and $164713.0 in Q3 2023.